CME - CME Group Inc Stock Price, Fair Value and News

210.39USD+2.05 (+0.98%)Delayed as of 08 May 2024, 02:39 pm ET

Market Summary

USD210.39+2.05

Delayedas of 08 May 2024, 02:39 pm

0.98%

CME Alerts

1 major insider sales recently.

CME Stock Price

View Fullscreen

CME RSI Chart

CME Valuation

Market Cap

74.8B

Price/Earnings (Trailing)

23.19

Price/Sales (Trailing)

13.2

EV/EBITDA

-4.67

Price/Free Cashflow

22.24

CME Price/Sales (Trailing)

CME Profitability

EBT Margin

75.19%

Return on Equity

11.88%

Return on Assets

2.44%

Free Cashflow Yield

4.5%

CME Fundamentals

CME Revenue

Revenue (TTM)

5.7B

Rev. Growth (Yr)

3.21%

Rev. Growth (Qtr)

11.16%

CME Earnings

Earnings (TTM)

3.2B

Earnings Growth (Yr)

27.7%

Earnings Growth (Qtr)

8.58%

Breaking Down CME Revenue

52 Week Range

175.73210.54

(Low)(High)

Last 7 days

-0.7%

Last 30 days

-1.3%

Last 90 days

1.4%

Trailing 12 Months

12.1%

How does CME drawdown profile look like?

CME Financial Health

Current Ratio

1.01

CME Investor Care

Dividend Yield

4.11%

Dividend/Share (TTM)

8.55

Shares Dilution (1Y)

0.09%

Diluted EPS (TTM)

8.79

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	5.7B	0	0	0
2023	5.8B	7.0B	7.6B	5.6B
2022	4.8B	3.9B	3.5B	5.7B
2021	4.6B	4.6B	4.6B	4.7B
2020	5.2B	5.1B	4.9B	4.9B
2019	4.4B	4.6B	5.0B	4.9B
2018	3.8B	4.0B	4.0B	4.3B
2017	3.6B	3.6B	3.7B	3.6B
2016	3.4B	3.5B	3.5B	3.6B
2015	3.2B	3.3B	3.4B	3.3B
2014	3.0B	2.9B	3.0B	3.1B
2013	2.9B	2.9B	2.9B	2.9B
2012	3.2B	3.2B	3.0B	2.9B
2011	3.1B	3.2B	3.3B	3.3B
2010	2.7B	2.8B	2.9B	3.0B
2009	2.6B	2.7B	2.6B	2.6B
2008	0	2.0B	2.3B	2.6B
2007	0	0	0	1.8B

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index

Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.

Returns of $10,000 invested in:

Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022

Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.

S&P 500 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of CME Group Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Apr 29, 2024	duffy terrence a	sold	-8,436,500	210	-40,000	chairman and ceo
Mar 26, 2024	shepard william r	bought	2,669	214	12.435	-
Mar 26, 2024	shepard william r	bought	60,561	214	282	-
Mar 15, 2024	fitzpatrick lynne	sold (taxes)	-71,557	217	-329	sr md chief financial officer
Mar 15, 2024	tobin jack j	acquired	117,668	217	541	md chief accounting officer
Mar 15, 2024	winkler julie	sold (taxes)	-619,222	217	-2,847	sr md chief commercial officer
Mar 15, 2024	winkler julie	acquired	1,397,440	217	6,425	sr md chief commercial officer
Mar 15, 2024	cutinho sunil	acquired	1,562,300	217	7,183	chief information officer
Mar 15, 2024	holzrichter julie	sold (taxes)	-728,625	217	-3,350	sr md chief operating officer

Which funds bought or sold CME recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 06, 2024	Matrix Trust Co	reduced	-0.44	29,000	1,657,000	0.38%
May 06, 2024	TEXAS PERMANENT SCHOOL FUND CORP	added	0.35	448,709	17,842,400	0.14%
May 06, 2024	Integrated Advisors Network LLC	reduced	-95.00	-4,169,410	224,795	0.01%
May 06, 2024	Valmark Advisers, Inc.	added	3.95	19,377	328,748	0.01%
May 06, 2024	Advisory Services Network, LLC	reduced	-41.83	-236,677	347,073	0.01%
May 06, 2024	Parallel Advisors, LLC	added	1.58	34,276	927,956	0.03%
May 06, 2024	YCG, LLC	reduced	-1.2	-52,888	12,794,100	1.02%
May 06, 2024	Manchester Capital Management LLC	added	22.08	56,767	285,690	0.04%
May 06, 2024	Van Hulzen Asset Management, LLC	unchanged	-	45,000	2,082,000	0.14%
May 06, 2024	DUALITY ADVISERS, LP	new	-	1,454,720	1,454,720	0.14%

Are Funds Buying or Selling CME?

Are funds buying CME calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own CME

No. of Funds

CME Alerts

1 major insider sales recently.

Unveiling CME Group Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	vanguard group inc	9.29%	33,450,782	SC 13G/A
Jan 26, 2024	blackrock inc.	6.7%	23,991,739	SC 13G/A
Feb 13, 2023	capital world investors	4.4%	15,768,261	SC 13G/A
Feb 09, 2023	vanguard group inc	9.21%	33,139,178	SC 13G/A
Jan 31, 2023	blackrock inc.	7.2%	26,025,197	SC 13G/A
Feb 11, 2022	capital world investors	9.3%	33,473,618	SC 13G/A
Feb 09, 2022	vanguard group inc	8.72%	31,356,965	SC 13G/A
Feb 03, 2022	blackrock inc.	6.7%	24,162,418	SC 13G/A
Feb 16, 2021	capital world investors	9.5%	33,945,618	SC 13G/A
Feb 10, 2021	vanguard group inc	7.86%	28,231,615	SC 13G/A

Recent SEC filings of CME Group Inc

View All Filings

Date Filed	Form Type	Document
May 01, 2024	10-Q	Quarterly Report
May 01, 2024	4	Insider Trading
Apr 29, 2024	144	Notice of Insider Sale Intent
Apr 25, 2024	8-K	Current Report
Apr 24, 2024	8-K	Current Report
Apr 03, 2024	4/A	Insider Trading
Mar 27, 2024	4	Insider Trading
Mar 22, 2024	4	Insider Trading
Mar 21, 2024	DEFA14A	DEFA14A
Mar 19, 2024	4	Insider Trading

Peers (Alternatives to CME Group Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
GS	143.1B	67.8B	8.75%	35.92%	15.2	2.11	66.36%	-10.82%
ICE	76.7B	9.7B	-2.99%	24.74%	30.93	7.89	0.75%	71.75%
CME	74.8B	5.7B	-1.35%	12.14%	23.19	13.2	-1.46%	19.89%
COIN	52.0B	4.0B	-11.04%	268.86%	38.54	13.1	41.89%	159.36%
FDS	16.6B	2.2B	0.54%	8.15%	33.93	7.71	7.26%	9.28%
IBKR	12.9B	6.1B	7.06%	54.42%	4.44	2.12	64.44%	33.59%
MID-CAP
JEF	9.7B	8.2B	4.15%	50.98%	33.44	1.18	17.04%	-68.59%
HLI	8.6B	1.8B	2.92%	55.51%	33.32	4.69	0.16%	-0.33%
EVR	7.4B	2.4B	-0.13%	79.36%	28.8	3.01	-12.10%	-46.39%
FRHC	4.2B	1.4B	1.89%	-10.83%	12.6	3.02	96.15%	398.80%
CLSK	3.3B	214.4M	5.96%	289.86%	-40.12	15.28	75.40%	19.03%
SMALL-CAP
DFIN	1.8B	802.0M	3.31%	48.27%	18.49	2.3	-2.34%	8.49%
AMRK	922.0M	10.0B	23.37%	10.15%	8.35	0.09	24.24%	-27.96%
COHN	16.1M	92.7M	14.99%	37.47%	2.58	0.17	72.05%	185.64%
AAMC	7.9M	3.2M	-18.39%	-96.27%	-0.24	2.5	-44.67%	-104.26%

CME Group Inc News

Latest updates

CME Group Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	11.2%	1,488	1,339	1,273	1,568	1,442	3,336	686	287	1,347	1,147	1,110	1,179	1,253	1,099	1,081	1,182	1,522	1,138	1,277	1,273	1,180
Costs and Expenses	-8.3%	528	576	518	522	528	540	489	488	488	516	496	505	528	584	556	545	562	565	592	574	549
EBITDA Margin	-	0.80*	-	0.56*	0.60*	0.71*	0.71*	1.16*	1.00*	0.79*	0.72*	0.73*	0.64*	0.70*	0.63*	0.63*	0.64*	0.64*	0.62*	0.60*	0.62*	0.65*
Income Taxes	34.9%	258	191	224	239	273	189	200	204	205	174	170	216	178	110	125	158	223	155	87.00	188	144
Earnings Before Taxes	-	1,113	-	974	1,016	1,157	-	880	867	916	-	1,096	726	752	-	537	661	989	624	723	702	640
EBT Margin	-	0.75*	-	0.53*	0.56*	0.66*	0.66*	1.08*	0.93*	0.73*	0.66*	0.67*	0.58*	0.64*	0.58*	0.57*	0.59*	0.58*	0.55*	0.55*	0.56*	0.60*
Net Income	-100.0%	-	815	750	778	884	638	680	663	711	625	927	510	574	424	412	503	766	470	636	514	497
Net Income Margin	-0.8%	0.57*	0.57*	0.40*	0.42*	0.50*	0.48*	0.77*	0.75*	0.58*	0.56*	0.52*	0.42*	0.41*	0.43*	0.44*	0.46*	0.46*	0.43*	0.41*	0.39*	0.42*
Free Cashflow	-14.7%	873	1,024	837	630	887	957	634	600	776	641	600	460	574	590	263	950	714	653	753	401	620

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	1.8%	132,054	129,706	125,598	151,297	166,039	174,176	178,432	176,671	205,918	196,780	186,774	178,699	160,652	124,660	125,759	117,215	137,932	75,215	79,418	70,350	71,615
Current Assets	2.5%	97,308	94,890	90,777	116,366	131,032	139,078	143,253	141,451	171,004	161,762	151,594	144,849	126,746	89,284	90,349	81,786	102,417	39,568	43,692	34,462	35,605
Cash Equivalents	3193.8%	95,916	2,912	2,300	1,880	1,565	2,720	2,130	1,880	2,046	2,835	1,459	1,081	936	88,420	1,332	1,405	852	38,634	1,210	938	997
Net PPE	-3.3%	396	410	417	430	440	456	466	482	494	505	521	528	529	579	547	539	538	544	517	500	468
Goodwill	-0.1%	10,490	10,495	10,478	10,491	10,491	10,483	10,447	10,484	10,516	10,528	10,529	10,543	10,534	10,799	10,756	10,743	10,743	10,743	10,774	10,795	10,850
Liabilities	1.9%	104,900	102,968	97,447	123,479	138,655	147,297	150,181	148,670	178,181	169,381	159,492	151,912	134,096	98,308	98,748	90,376	111,334	49,056	52,604	43,865	45,428
Current Liabilities	2.9%	96,101	93,417	87,881	113,886	129,044	137,688	140,573	139,000	168,459	160,398	150,417	142,013	124,223	88,198	88,631	80,201	101,054	38,523	41,914	32,935	34,272
Short Term Borrowings	-	749	-	-	-	16.00	16.00	15.00	-	-	749	749	-	-	-	-	-	-	-	-	-	-
Shareholder's Equity	1.6%	27,154	26,738	28,152	22,311	22,285	26,879	28,251	28,002	27,737	27,399	27,282	26,787	26,556	26,352	27,010	26,839	26,599	26,159	26,813	26,485	26,187
Retained Earnings	9.8%	4,891	4,455	5,956	5,607	5,230	4,747	6,112	5,798	5,499	5,152	6,037	5,435	5,247	4,996	5,775	5,669	5,470	5,009	5,704	5,337	5,091
Additional Paid-In Capital	0.0%	22,346	22,335	22,309	22,308	22,282	22,262	22,235	22,232	22,206	22,190	21,204	21,219	21,194	21,186	21,157	21,149	21,120	21,113	21,108	21,109	21,062
Accumulated Depreciation	3.0%	959	931	904	874	1,175	1,145	1,111	1,097	1,071	1,039	1,046	980	947	961	932	894	886	868	837	844	790
Shares Outstanding	0.1%	359	359	359	359	359	359	359	359	359	358	358	358	358	358	358	358	358	357	357	357	357
Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	24.00	28.00	32.00	31.00	31.00	31.00	30.00	30.00	30.00	29.00
Float	-	-	-	-	66,300	-	-	-	73,200	-	-	-	76,000	-	-	-	57,900	-	-	-	68,500	-

Cashflow (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Cashflow (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	-14.5%	893	1,044	857	650	902	982	658	618	799	668	632	500	603	660	311	987	757	720	810	474	669
Share Based Compensation	-4.1%	23.00	24.00	19.00	20.00	20.00	26.00	19.00	19.00	20.00	19.00	16.00	19.00	22.00	27.00	24.00	22.00	23.00	2.00	14.00	38.00	18.00
Cashflow From Investing	-11.8%	-22.80	-20.40	-19.50	78.00	-17.20	-25.70	-23.60	-417	-22.90	68.00	59.00	-34.00	-34.00	-52.10	-43.90	-36.50	-43.00	-15.90	-46.80	-41.30	-48.60
Cashflow From Financing	-25.2%	1,936	2,589	-26,466	-15,262	-9,198	-5,091	1,161	-29,672	8,222	9,395	7,550	17,565	35,399	49,398	-340	-396	-1,413	-363	-490	-489	-997
Dividend Payments	-100.0%	-	400	400	400	2,036	364	363	363	1,544	327	323	323	1,218	304	304	304	1,198	268	268	268	892

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

CME Income Statement

2024-03-31

Consolidated Statements Of Income - USD ($) shares in Thousands, $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenues
Total Revenues	$ 1,487.9	$ 1,441.6
Expenses
Compensation and benefits	206.0	204.5
Technology	59.4	51.3
Professional fees and outside services	33.1	38.3
Amortization of purchased intangibles	55.2	56.8
Depreciation and amortization	30.1	31.9
Licensing and other fee agreements	87.9	84.7
Other	56.6	60.4
Total Expenses	528.3	527.9
Operating Income	959.6	913.7
Non-Operating Income (Expense)
Investment income	1,071.3	1,357.7
Interest and other borrowing costs	(39.9)	(39.9)
Equity in net earnings of unconsolidated subsidiaries	87.2	78.2
Other non-operating income (expense)	(964.8)	(1,152.8)
Total Non-Operating Income (Expense)	153.8	243.2
Income before Income Taxes	1,113.4	1,156.9
Income tax provision	258.2	273.1
Net Income	855.2	883.8
Net Income Attributable to Common Shareholders of CME Group	$ 844.4	$ 872.7
Earnings per Share Attributable to Common Shareholders of CME Group:
Basic (in dollars per share)	$ 2.35	$ 2.43
Diluted (in dollars per share)	$ 2.35	$ 2.43
Weighted Average Number of Common Shares:
Basic (in shares)	359,258	358,933
Diluted (in shares)	359,833	359,313
Clearing and transaction fees [Member]
Revenues
Total Revenues	$ 1,208.9	$ 1,200.2
Market data and information services
Revenues
Total Revenues	175.4	165.8
Other
Revenues
Total Revenues	$ 103.6	$ 75.6

CME Balance Sheet

2024-03-31

Consolidated Balance Sheets - USD ($)
$ in Millions

Mar. 31, 2024

Dec. 31, 2023

Assets

Cash and cash equivalents

$ 1,436.9

$ 2,912.0

Marketable securities

121.0

111.7

Accounts receivable, net of allowance of $7.9 and $7.1

628.2

535.6

Other current assets (includes $5.2 in restricted cash)

647.7

1,138.4

Performance bonds and guaranty fund contributions

94,473.9

90,192.5

Total current assets

97,307.7

94,890.2

Property, net of accumulated depreciation and amortization of $958.8 and $931.1

396.0

409.5

Intangible assets—trading products

^[1]

17,175.3

Intangible assets—other, net

2,990.0

3,050.2

Goodwill

10,489.6

10,495.3

Other assets

3,695.1

3,685.6

Total Assets

132,053.7

129,706.1

Liabilities and Equity

Accounts payable

111.0

90.6

Short-term Debt

749.3

0.0

Other current liabilities

767.2

3,133.8

Performance bonds and guaranty fund contributions

94,473.9

90,192.5

Total current liabilities

96,101.4

93,416.9

Long-term debt

2,676.7

3,425.4

Deferred income tax liabilities, net

5,317.2

5,327.7

Other liabilities

804.2

798.2

Total Liabilities

104,899.5

102,968.2

Shareholders' Equity:

Preferred stock, $0.01 par value, 10,000 shares authorized as of March 31, 2024 and December 31, 2023; 4,584 issued and outstanding as of March 31, 2024 and December 31, 2023

0.0

Additional paid-in capital

22,345.6

22,334.7

Retained earnings

4,891.1

4,455.2

Accumulated other comprehensive income (loss)

(86.1)

(55.6)

Total CME Group Shareholders’ Equity

27,154.2

26,737.9

Total Liabilities and Equity

132,053.7

129,706.1

Class A Common Stock [Member]

Shareholders' Equity:

Common stock

3.6

Class B Common Stock [Member]

Shareholders' Equity:

Common stock

$ 0.0

[1]

Trading products represent futures and options products acquired in our business combinations with CBOT Holdings, Inc., NYMEX Holdings, Inc. and The Board of Trade of Kansas City, Missouri, Inc. Clearing and transaction fees are generated through the trading of these products. These trading products, most of which have traded for decades, require authorization from the Commodity Futures Trading Commission (CFTC). Product authorizations from the CFTC have no term limits.

About CME Group Inc

CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois.

CEO	Mr. Terrence A. Duffy
WEBSITE	cmegroup.com
INDUSTRY	Mortgage Finance
EMPLOYEES	3460

CME Group Inc Frequently Asked Questions

What is the ticker symbol for CME Group Inc? What does CME stand for in stocks?

CME is the stock ticker symbol of CME Group Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of CME Group Inc (CME)?

As of Tue May 07 2024, market cap of CME Group Inc is 74.81 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of CME stock?

You can check CME's fair value in chart for subscribers.

What is the fair value of CME stock?

You can check CME's fair value in chart for subscribers. The fair value of CME Group Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of CME Group Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for CME so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is CME Group Inc a good stock to buy?

The fair value guage provides a quick view whether CME is over valued or under valued. Whether CME Group Inc is cheap or expensive depends on the assumptions which impact CME Group Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CME.

What is CME Group Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue May 07 2024, CME's PE ratio (Price to Earnings) is 23.19 and Price to Sales (PS) ratio is 13.2. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CME PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on CME Group Inc's stock?

In the past 10 years, CME Group Inc has provided 0.156 (multiply by 100 for percentage) rate of return.